Clinical Trial Update: Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bintrafusp alfa before surgery for untreated resectable non-small cell lung cancer was terminated; results were posted in 2022…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2022-07-28